Moving to benefit-based medicine with a lifetime risk model
Current CV risk scores overestimate risk in elderly and underestimate risk in young subjects. Prof. Frank Visseren emphasizes the need of CV lifetime risk prediction and presents the U-prevent calculator that estimates gain in CVD-free life based on lifetime CV risk and treatment effects in individuals.
Video navigation menu
- Challenges in CV risk prediction in healthy people 03:42
- Models for lifetime CV risk and treatment effects 05:41
- U-prevent estimates gain in CVD-free life 08:07
- Moving to benefit-based medicine 11:23
This lecture by prof. Frank Visseren was part of a CME accredited symposium: "New concepts and models in CV risk management" held at ESC 2018 in Munich, Germany.
Professor Frank Visseren, MD - Internist, Epidemiologist and Professor in Vascular Medicine at the University Medical Center in Utrecht, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Pfizer.